Viewing Study NCT00163735



Ignite Creation Date: 2024-05-05 @ 11:53 AM
Last Modification Date: 2024-10-26 @ 9:15 AM
Study NCT ID: NCT00163735
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2005-09-12

Brief Title: Potential Allergens in Wine Double-blind Placebo-controlled Trial
Sponsor: Bayside Health
Organization: Bayside Health

Study Overview

Official Title: Potential Allergens in Wine Double Blind Placebo-controlled Trial and Basophil Activation Analysis
Status: COMPLETED
Status Verified Date: 2005-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study is designed to identify whether wines which are produced using the common potential food allergens such as proteins derived from fish milk or egg are likely to contain sufficient food allergens to cause allergic reactions in susceptible individuals
Detailed Description: Recent international legislation requires labelling of wines made using potentially allergenic food proteins casein egg white isinglass fish derived milk or evaporated milk where there is detectable residual processing aid However it is not clear whether the final wine contains concentrations of residual added food proteins that can provoke allergic reactions

ComparisonThis study is a double blind placebo-controlled trial to determine whether adults known to be allergic to eggs fish milk andor nuts exhibit allergic reactions following consumption of Australian commercial wines fined with food allergens

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
Number 12402 None None None